ctrl K

Watchlist Price Alert

Bellerophon Therapeutics ... (BLPH)

NASDAQ: BLPH · Real-Time Price · USD

0.01

-0.01 (-47.37%)

At close: Dec 18, 2024, 5:51 PM

Bellerophon Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	6.92M	24.74M	47.56M	9.87M	16.64M	28.82M	14.45M
Short-Term Investments	405K	n/a	n/a	n/a	n/a	3M	5.57M
Long-Term Investments	n/a	300K	300K	300K	300K	150K	307K
Other Long-Term Assets	186K	186K	186K	n/a	n/a	54K	1.49M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	234K	103K	103K	103K	101K	402K	401K
Total Current Assets	7.56M	25.46M	48.08M	10.38M	17.4M	35.58M	26.5M
Property-Plant & Equipment	186K	930K	1.67M	2.43M	664K	1.03M	1.4M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	372K	1.42M	2.16M	2.73M	964K	1.23M	3.2M
Total Assets	7.93M	26.88M	50.24M	13.11M	18.36M	36.81M	29.7M
Account Payables	1.23M	1.19M	3.73M	3.11M	2.75M	3.85M	2.81M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	752K	704K	658K	n/a	n/a	n/a
Other Current Liabilities	n/a	-752K	-704K	-658K	n/a	n/a	n/a
Total Current Liabilities	5.4M	5.05M	10.43M	7.58M	7.54M	7.08M	6.5M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	1K	601K	274K	6.96M	32.33M	5.21M
Total Long-Term Liabilities	n/a	204K	1.56M	1.93M	6.96M	32.33M	5.21M
Total Liabilities	5.4M	5.26M	11.99M	9.52M	14.5M	39.4M	11.71M
Total Debt	203K	955K	1.66M	2.32M	n/a	n/a	n/a
Common Stock	96K	95K	95K	46K	587K	569K	317K
Retained Earnings	-252.08M	-232.25M	-214.49M	-189.76M	-176.5M	-179.31M	-124.49M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	-4K	n/a
Shareholders Equity	2.53M	21.62M	38.25M	3.59M	3.86M	-2.59M	17.99M
Total Investments	405K	300K	300K	300K	300K	3M	5.57M